Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

255 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 255 results

Testing effectiveness (Phase 2)Study completedNCT01610557
What this trial is testing

Ranibizumab and Bevacizumab for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
National Eye Institute (NEI) 56
Not applicableUnknownNCT05342857
What this trial is testing

Maximum Treatment Interval With Aflibercept T&E

Who this might be right for
Neovascular Age-related Macular Degeneration
Shin Kong Wu Ho-Su Memorial Hospital 100
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Not applicableStudy completedNCT04241198
What this trial is testing

Home Retinal Imaging Using NOTAL-OCT V3.0

Who this might be right for
A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment
Notal Vision Ltd. 10
Post-approval studies (Phase 4)Study completedNCT01495221
What this trial is testing

To Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMD

Who this might be right for
AMD (With Persistent or Recurrent Fluid Despite Monthly Intravitreal Anti-VEGF Therapy)
Vitreous -Retina- Macula Consultants of New York 9
Not applicableActive Not RecruitingNCT06717139
What this trial is testing

Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD

Who this might be right for
Retinal DiseasesMacular DegenerationNeovascular (Wet) Age-Related Macular Degeneration
St. Erik Eye Hospital 220
Not applicableLooking for participantsNCT07224841
What this trial is testing

Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

Who this might be right for
CRC (Colorectal Cancer)
City of Hope Medical Center 500
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Early research (Phase 1)Ended earlyNCT00704821
What this trial is testing

PTC299 for Treatment of Advanced Cancer

Who this might be right for
Advanced Cancer
PTC Therapeutics 76
Not applicableStudy completedNCT04982484
What this trial is testing

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab Treatment

Who this might be right for
OphthalmopathyWet Macular Degeneration
Centre Hospitalier Régional Metz-Thionville 50
Not applicableStudy completedNCT01933152
What this trial is testing

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 137
Testing effectiveness (Phase 2)UnknownNCT03973112
What this trial is testing

A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Henlius Biotech 123
Large-scale testing (Phase 3)Study completedNCT00601900
What this trial is testing

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Invasive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer AJCC v6+1 more
National Cancer Institute (NCI) 394
Not applicableUnknownNCT01023971
What this trial is testing

Macular Function During Anti-VEGF Treatment

Who this might be right for
Age Related Macular Degeneration
Royal Liverpool University Hospital 40
Not applicableUnknownNCT03866005
What this trial is testing

Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema

Who this might be right for
Center-involved Diabetic Macular Edema (CI-DME)
ZeaVision, LLC 150
Not applicableUnknownNCT04976244
What this trial is testing

Brolucizumab for CNV Associated With Pathologic Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 50
Not applicableStudy completedNCT01549132
What this trial is testing

Retinal Oximtery Following Treatment for Diabetic Maculopathy

Who this might be right for
Diabetic Maculopathy
East Kent Hospitals University NHS Foundation Trust 45
Early research (Phase 1)Study completedNCT01120288
What this trial is testing

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Who this might be right for
NeoplasmsLiver Metastases
National Cancer Institute (NCI) 10
Not applicableLooking for participantsNCT07235527
What this trial is testing

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Saglik Bilimleri Universitesi 54
Testing effectiveness (Phase 2)Study completedNCT02397954
What this trial is testing

Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation 4
Load More Results